| Application no. and date | 21739730.6 (espacenet) (Federated) (European Patent Register), 20210714 | | Patent/reg. no. and date | DK/EP 4181872, 20251126 | | Publication date | 20230524 | | Priority no. and date | WO PCT/EP2020/069976, 20200715 | | EP pub. no. and date |
EP 4181872 20230524 | | Effective date | | | Applicant/owner | Viatris Asia Pacific Pte. Ltd., 2 Shenton Way, No. 18-01
SGX Centre 1
Singapore 068864, SG | | Applicant ref. no. | V2601-003-DK | | Inventor | VON RAUMER, Markus,
4123 Allschwil, CH,
BUCHMANN, Stephan,
4056 Basel, CH,
FRAICHARD, Amandine,
4123 Allschwil, CH,
HERRMANN, Charlyse,
4123 Allschwil, CH,
LIENHART, Céline,
4123 Allschwil, CH,
WERK, Tobias,
4125 Riehen, CH | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61K 47/02 (2006.01) , A61K 47/18 (2017.01) , A61K 9/00 (2006.01) , A61K 9/08 (2006.01) , A61P 7/02 (2006.01) | | Title | VANDIG, FARMACEUTISK SAMMENSÆTNING OMFATTENDE EN P2Y12 RECEPTORANTAGONIST | | Int. application no. | EP2021069579 | | Int. publication no. | WO2022013276 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
